Chen Ruoxi 4
4 · Silk Road Medical Inc · Filed Jul 13, 2020
Insider Transaction Report
Form 4
Chen Ruoxi
Director
Transactions
- Award
Option (right to buy)
2020-07-08+4,482→ 4,482 totalExercise: $44.62From: 2021-06-05Exp: 2030-07-08→ Common Stock (4,482 underlying) - Award
Option (right to buy)
2020-07-08+2,390→ 2,390 totalExercise: $44.62From: 2020-09-05Exp: 2030-07-08→ Common Stock (2,390 underlying) - Award
Common Stock
2020-07-08+644→ 644 total
Footnotes (4)
- [F1]The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. All of the RSUs vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the Issuer's 2021 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date.
- [F2]All of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date the award is granted or (ii) the day prior to the date of the Issuer's 2021 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date.
- [F3]The shares subject to the options represent cash retainer and any additional fees that the Reporting Person elected to receive in the form of stock options.
- [F4]One fourth of the shares subject to the option shall vest on each of September 5, 2020, December 5, 2020, March 5, 2021, and the date of the Issuer's 2021 annual meeting of stockholders, subject to the Reporting Person continuing as a service provider through each such date.